Atossa Therapeutics, Inc.
ATOSNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $24.23M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.86$14.85
- Volume (live)
- -
- Avg. volume (3M)
- 88.76K
Atossa Therapeutics (ATOS) Stock Price & Financial Analysis
Atossa Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.46 - $2.77 |
|---|---|
| 52-Week High | $14.85 |
| 52-Week Low | $0.86 |
| Open | $2.49 |
| Volume (last close) | 90.62K |
| Average Volume (3M) | 88.76K |
| 50-Day MA | $2.44 |
|---|---|
| 200-Day MA | $4.23 |
| 1-Year Change | +197.14% |
| Market Cap | 24.23M |
|---|---|
| Shares Outstanding | 8.91M |
| Price to Book (P/B) | 0.90 |
| EV/EBITDA | 0.05 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Atossa Therapeutics at a Glance
As of the Oct 22, 2026 close, Atossa Therapeutics (ATOS) has a market capitalization of $24.23M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $26.09M in cash and securities against $0.00 of debt, a net cash position of $26.09M.
Atossa Therapeutics does not currently pay a dividend.
The share price is up 197.1% over the past year. At $2.72 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.86 to $14.85, below its 200-day moving average of $4.23.
Frequently Asked Questions About Atossa Therapeutics
What is the current stock price for ATOS?
As of the Oct 22, 2026 close, ATOS stock trades at $2.72. The 52-week range is $0.86–$14.85, with a day range of $2.46–$2.77.
What is the P/E ratio for ATOS?
The P/E ratio (Price-to-Earnings) for ATOS is shown in the Key Statistics section. This valuation metric helps compare Atossa Therapeutics, Inc. to industry peers.
Does ATOS pay dividends?
Atossa Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ATOS?
Analyst ratings and recommendations for ATOS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ATOS?
As of the Oct 22, 2026 close, Atossa Therapeutics's market capitalization is $24.2M, classifying it as a micro-cap company. Atossa Therapeutics operates in the Healthcare sector within the Biotechnology industry.